These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12653082

  • 1. [New therapeutic approaches to age dependent macular degeneration].
    Holz FG.
    Ophthalmologe; 2003 Feb; 100(2):90-1. PubMed ID: 12653082
    [No Abstract] [Full Text] [Related]

  • 2. [Pathogenesis of choroidal neovascularization. Old concepts, new questions].
    Fauser S, Engelmann K, Krohne TU, Lappas A, Kirchhof B, Joussen AM.
    Ophthalmologe; 2003 Apr; 100(4):300-5. PubMed ID: 12682762
    [Abstract] [Full Text] [Related]

  • 3. Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls.
    Csaky K.
    Ophthalmology; 2003 May; 110(5):879-81. PubMed ID: 12750083
    [No Abstract] [Full Text] [Related]

  • 4. [The molecular mechanisms of neovascular age-related macular degeneration].
    Miller DW, Joussen AM, Holz FG.
    Ophthalmologe; 2003 Feb; 100(2):92-6. PubMed ID: 12589451
    [Abstract] [Full Text] [Related]

  • 5. [Angiogenesis in ophthalmology. A theme with a future].
    Joussen AM, Kirchhof B.
    Ophthalmologe; 2003 Apr; 100(4):281-3. PubMed ID: 12723577
    [No Abstract] [Full Text] [Related]

  • 6. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.
    Schwesinger C, Yee C, Rohan RM, Joussen AM, Fernandez A, Meyer TN, Poulaki V, Ma JJ, Redmond TM, Liu S, Adamis AP, D'Amato RJ.
    Am J Pathol; 2001 Mar; 158(3):1161-72. PubMed ID: 11238064
    [Abstract] [Full Text] [Related]

  • 7. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N.
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [Abstract] [Full Text] [Related]

  • 8. A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization.
    He S, Jin ML, Worpel V, Hinton DR.
    Arch Ophthalmol; 2003 Sep; 121(9):1283-8. PubMed ID: 12963611
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacological therapy for age-related macular degeneration. Current developments and perspectives].
    Holz FG, Miller DW.
    Ophthalmologe; 2003 Feb; 100(2):97-103. PubMed ID: 12589452
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.
    Ohno-Matsui K, Yoshida T, Uetama T, Mochizuki M, Morita I.
    Biochem Biophys Res Commun; 2003 Apr 11; 303(3):962-7. PubMed ID: 12670505
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factors and angiogenesis in eye disease.
    Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO.
    Prog Retin Eye Res; 2003 Jan 11; 22(1):1-29. PubMed ID: 12597922
    [Abstract] [Full Text] [Related]

  • 12. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.
    Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Hayano M, Murota SI, Mochizuki M.
    J Cell Physiol; 2001 Dec 11; 189(3):323-33. PubMed ID: 11748590
    [Abstract] [Full Text] [Related]

  • 13. Age-related macular degeneration (AMD): pathogenesis and therapy.
    Nowak JZ.
    Pharmacol Rep; 2006 Dec 11; 58(3):353-63. PubMed ID: 16845209
    [Abstract] [Full Text] [Related]

  • 14. Angiogenesis and angiogenic mediators in haematological malignancies.
    Mangi MH, Newland AC.
    Br J Haematol; 2000 Oct 11; 111(1):43-51. PubMed ID: 11091181
    [No Abstract] [Full Text] [Related]

  • 15. Age-related maculopathy: pathogenetic features and new treatment modalities.
    Algvere PV, Seregard S.
    Acta Ophthalmol Scand; 2002 Apr 11; 80(2):136-43. PubMed ID: 11952478
    [Abstract] [Full Text] [Related]

  • 16. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results.
    Eyetech Study Group.
    Ophthalmology; 2003 May 11; 110(5):979-86. PubMed ID: 12750101
    [Abstract] [Full Text] [Related]

  • 17. The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization.
    Monaghan-Benson E, Hartmann J, Vendrov AE, Budd S, Byfield G, Parker A, Ahmad F, Huang W, Runge M, Burridge K, Madamanchi N, Hartnett ME.
    Am J Pathol; 2010 Oct 11; 177(4):2091-102. PubMed ID: 20802176
    [Abstract] [Full Text] [Related]

  • 18. Anti-angiogenesis: biology is the foundation for therapy.
    Gerber HP.
    Drug Discov Today; 2003 Apr 15; 8(8):344-6. PubMed ID: 12681937
    [No Abstract] [Full Text] [Related]

  • 19. Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development.
    Sepp-Lorenzino L, Thomas KA.
    Expert Opin Investig Drugs; 2002 Oct 15; 11(10):1447-65. PubMed ID: 12387705
    [Abstract] [Full Text] [Related]

  • 20. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S, Lyden D, Benezra R, Hattori K, Heissig B.
    Nat Rev Cancer; 2002 Nov 15; 2(11):826-35. PubMed ID: 12415253
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.